Gabrielle Sulzberger - Dec 31, 2022 Form 5 Insider Report for Cerevel Therapeutics Holdings, Inc. (CERE)

Role
Director
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
Stock symbol
CERE
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
5
Date filed
2/14/2023, 04:47 PM
Previous filing
Dec 20, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERE Common Stock Gift $0 -49.6K -77.67% $0.00 14.3K Oct 3, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.